WHO ICTRP trial
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in…
JPRN-UMIN000006750 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000006750 |
|---|---|
| Public title | Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in Stage III colon cancer |
| Scientific title | Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in Stage III colon cancer - N-SOG 08 |
| Primary sponsor | Nagoya Surgical Oncology Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Colon cancer |
| Interventions | TS-1 is administered orally at a dose of 80 mg/m2/day b.i.d. for 28 days followed by 14 days of rest. Cycles are repeated every 6 weeks until 4 courses. TS-1 is administered orally at a dose of 80 mg/m2/day b.i.d. for 14 days followed by 7… |
| Registration date | Nov 20, 2011 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: